Title: Instructions for Authors Document date: 2015_1_5
ID: 0pfgdbxb_80
Snippet: Wang YS, Miao LY, Liu L, Cai HR, Ding JJ, Ren SX, et al. Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with clinical outcome of erlotinib treatment. Chin Med J 2013; 126: 3931-3935.Xie SZ, Gu MJ, Cheng YP. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm (in Chinese). Chin J Obstet Gynecol 1998; 33: 113-114.Dannenberg AM. Immune mechanisms in the pathogenesis .....
Document: Wang YS, Miao LY, Liu L, Cai HR, Ding JJ, Ren SX, et al. Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with clinical outcome of erlotinib treatment. Chin Med J 2013; 126: 3931-3935.Xie SZ, Gu MJ, Cheng YP. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm (in Chinese). Chin J Obstet Gynecol 1998; 33: 113-114.Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11 Suppl 2: s369-s378.Payne DK, Sullivan MD, Massie MJ. Women's psychological reactions to breast cancer. Semin Oncol 1996; 23 (1 Suppl 2): 89-97.Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995; 32 (Pt 3): 303-306.Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-114.
Search related documents:
Co phrase search for related documents- advanced non small cell lung cancer and cell lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- advanced non small cell lung cancer and clinical outcome: 1
- breast cancer and cell lung: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- breast cancer and cell lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- breast cancer and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- breast cancer and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8, 9
- breast cancer and malignant neoplasm: 1, 2
- cell lung and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- cell lung and cytokine level: 1
- cell lung and erlotinib treatment: 1
- cell lung and immune mechanism: 1, 2
- cell lung and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8
- cell lung cancer and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cell lung cancer and erlotinib treatment: 1
- cell lung cancer and inhibitory effect: 1, 2, 3
- clinical outcome and cytokine level: 1, 2
- clinical outcome and erlotinib treatment: 1
- clinical outcome and immune mechanism: 1, 2, 3, 4
- clinical outcome and inhibitory effect: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date